FIELD: medicine, pharmacy. SUBSTANCE: invention proposes a medicinal composition consisting of pyroglutamic acid and pyrrolidone. Medicinal composition improves circulation and metabolic processes in brain tissue and can be used for treatment of cerebral ischemic injury. EFFECT: valuable medicinal properties of composition. 2 cl, 1 dwg, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATMENT OF BRAIN ISCHEMIC INJURY | 2004 |
|
RU2288714C2 |
DRUG FOR IMPROVING BLOOD SUPPLY OF ISCHEMIZED BRAIN | 2019 |
|
RU2747202C2 |
INJECTION DOSAGE FORM FOR ACUTE STROKE TREATMENT, METHOD OF PRODUCTION AND APPLICATION THEREOF | 2005 |
|
RU2330680C2 |
SUCCINIC ACID ESTERS OF 5-HYDROXYADAMANTAN-2-ONE, IMPROVING BLOOD SUPPLY TO ISCHEMIC BRAIN | 2017 |
|
RU2658833C1 |
ANTIHYPOXY PREPARATION FOR TREATING ISCHEMIA AND CEREBRAL BLOOD CIRCULATION | 1990 |
|
RU2016579C1 |
NEUROPROTECTOR | 2009 |
|
RU2406488C1 |
PHARMACEUTICAL COMPOSITIONS CONTAINING S-AMLODIPINE NICOTINATE AND USING THEM IN TREATING CEREBROVASCULAR DISORDERS | 2012 |
|
RU2516922C2 |
METHOD FOR MODELLING CEREBRAL ISCHEMIA DISEASE AGGRAVATED BY HEMISPHERE ASYMMETRY PHENOMENA | 1993 |
|
RU2083000C1 |
USE OF PHARMACEUTICAL COMPOSITION CONTAINING CHOLINE ALFOSCERATE AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE AS NEUROPROTECTIVE AGENT IN CEREBRAL ISCHEMIA | 2023 |
|
RU2819828C1 |
AGENT POSSESSING NEUROPROTECTIVE ACTION IN ISCHEMIC CEREBRAL CIRCULATION DISORDER | 2015 |
|
RU2586301C1 |
Authors
Dates
2003-10-10—Published
2001-03-14—Filed